These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7933233)

  • 1. Expectant management of early stage prostatic cancer: Swedish experience.
    Johansson JE
    J Urol; 1994 Nov; 152(5 Pt 2):1753-6. PubMed ID: 7933233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High 10-year survival rate in patients with early, untreated prostatic cancer.
    Johansson JE; Adami HO; Andersson SO; Bergström R; Holmberg L; Krusemo UB
    JAMA; 1992 Apr 22-29; 267(16):2191-6. PubMed ID: 1556796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Natural disease course in untreated early prostatic carcinoma--the Orebro Study].
    Johansson JE
    Praxis (Bern 1994); 2001 Sep; 90(36):1507-14. PubMed ID: 11593906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of localised prostatic cancer. A population-based study in 223 untreated patients.
    Johansson JE; Adami HO; Andersson SO; Bergström R; Krusemo UB; Kraaz W
    Lancet; 1989 Apr; 1(8642):799-803. PubMed ID: 2564901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history of early, localized prostate cancer.
    Johansson JE; Andrén O; Andersson SO; Dickman PW; Holmberg L; Magnuson A; Adami HO
    JAMA; 2004 Jun; 291(22):2713-9. PubMed ID: 15187052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The natural course of untreated, localized primary prostate carcinoma].
    Johansson JE
    Urologe A; 1996 Nov; 35(6):446-8. PubMed ID: 9064880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden.
    Johansson JE; Holmberg L; Johansson S; Bergström R; Adami HO
    JAMA; 1997 Feb; 277(6):467-71. PubMed ID: 9020270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer.
    Zincke H; Lau W; Bergstralh E; Blute ML
    J Urol; 2001 Dec; 166(6):2208-15. PubMed ID: 11696737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors.
    Zincke H; Bergstralh EJ; Larson-Keller JJ; Farrow GM; Myers RP; Lieber MM; Barrett DM; Rife CC; Gonchoroff NJ
    Cancer; 1992 Jul; 70(1 Suppl):311-23. PubMed ID: 1600493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer.
    Zincke H; Oesterling JE; Blute ML; Bergstralh EJ; Myers RP; Barrett DM
    J Urol; 1994 Nov; 152(5 Pt 2):1850-7. PubMed ID: 7523733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome in patients with pTxN+ adenocarcinoma of prostate treated with radical prostatectomy and early androgen ablation.
    Seay TM; Blute ML; Zincke H
    J Urol; 1998 Feb; 159(2):357-64. PubMed ID: 9649239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expectant management of clinically localized prostatic cancer.
    Warner J; Whitmore WF
    J Urol; 1994 Nov; 152(5 Pt 2):1761-5. PubMed ID: 7933234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can radical prostatectomy alter the progression of poorly differentiated prostate cancer?
    Ohori M; Goad JR; Wheeler TM; Eastham JA; Thompson TC; Scardino PT
    J Urol; 1994 Nov; 152(5 Pt 2):1843-9. PubMed ID: 7523732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of early, localized prostate cancer: a final report from three decades of follow-up.
    Popiolek M; Rider JR; Andrén O; Andersson SO; Holmberg L; Adami HO; Johansson JE
    Eur Urol; 2013 Mar; 63(3):428-35. PubMed ID: 23084329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of incidental prostatic cancer in Aust-Agder County, Norway.
    Waaler G; Ludvigsen TC; Stenwig AE
    Eur Urol; 1990; 18(3):179-83. PubMed ID: 1702057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Prostate Cancer Intervention Versus Observation Trial: a randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer.
    Wilt TJ; Brawer MK
    J Urol; 1994 Nov; 152(5 Pt 2):1910-4. PubMed ID: 7523736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deferred treatment in localized prostatic cancer.
    Johansson JE; Andersson SO
    Acta Oncol; 1991; 30(2):221-3. PubMed ID: 2029410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage D1 prostate cancer. A nonrandomized comparison of conservative treatment options versus radical prostatectomy.
    Cheng CW; Bergstralh EJ; Zincke H
    Cancer; 1993 Feb; 71(3 Suppl):996-1004. PubMed ID: 7679047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deferred treatment of clinically localized low grade prostate cancer: the experience from a prospective series at the Karolinska Hospital.
    Adolfsson J; Rönström L; Löwhagen T; Carstensen J; Hedlund PO
    J Urol; 1994 Nov; 152(5 Pt 2):1757-60. PubMed ID: 7523723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.